Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• CV complications of pregnancy: A call for greater awareness
• L. Kristin Newby, MD, MHS, ponders path from lab to clinic
• 2 decades of molecular cardiology and genetics Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Brandon A. Roberts, MSc, MD; Calvin W. Roberts, MD; William L. Roberts, MHA, CPA
• FDA approves BevyxXa for prevention of venous thromboembolism
• FDA committee supports expanded CV indication for liraglutide in adults with type 2 diabetes
• Self-expanding TAVR system approved for use in intermediate-risk patients
• Awareness of women’s CV health, CVD risk low among patients, physicians
• Monogenic, polygenic risk for CVD may be lowered by lifestyle changes, statin therapy
• Q&A: Nieca Goldberg, MD, discusses strategies to encourage CV awareness
• ACC committee: Sex disparities evident in heart health care
• Adherence to lipid-management guidelines benefits patients with CLI
• AHA: Polyunsaturated fats as substitute for saturated fats lower risk for CVD
• ANGPTL3 antagonism may further decrease lipid levels, risk for CVD
• ATHOS-3: Angiotensin II may increase BP in patients with vasodilatory shock
• Cardiology care soon after AF diagnosis tied to lower stroke risk
• Clonal hematopoiesis of indeterminate potential increases CHD risk
• Cocaine abuse harms CV system
• Compound intervention fails to improve readmission, medication adherence after acute MI
• DAPT score can identify patients who may benefit from shorter DAPT
• Direct oral anticoagulants may be underprescribed to patients with AF, high stroke risk
• Fat tissue measurement with CTA may prevent MI, CVD
• Health care expansion through ACA may have reduced incidence of cardiac arrest
• Herpes zoster linked to elevated risk for MI, stroke
• HF hospitalizations remain more common in men, black patients
• HF malignancy similar to certain cancers
• Idarucizumab safely reverses anticoagulant effect of dabigatran
• Improved diet quality may reduce risk for death
• Intensive BP lowering may reduce risk for LV hypertrophy
• Long-term aspirin use in older patients increases risk for major bleeding
• Minor lifestyle improvements may decrease high BP risk in black adults
• New-generation DES consistent, durable over 3 years in women with acute MI
• NIH funding for cardiac arrest research decreased in past 10 years
• Patients with ICDs may engage in sports
• Pregnancy complications increase risk for premature CHD in adults
• Running and the heart: Multiple marathons do not raise atherosclerosis risk
• Select traditional Chinese medicine may benefit patients with heart disease
• Systolic BP levels below guideline targets may decrease CVD, mortality risk
• UTROPIA: Single high-sensitivity cardiac troponin I measurement at presentation may rule out acute MI
• Ralinepag may improve pulmonary vascular resistance in patients with PAH
• REVEAL: Anacetrapib plus atorvastatin reduces coronary events in high-risk patients
• USPSTF recommends screening for obesity in children, adolescents
• AUGMENT-HF: Implant procedure continues to benefit patients with HF
• CVD-REAL: SGLT2 inhibitors benefit patients with diabetes, irrespective of CV history
• DEVOTE: Insulin degludec demonstrates CV safety, reduced risk for severe hypoglycemia
• Reactive antitachycardia pacing therapy linked to lower AF progression rates
• Patient-specific pharmacotherapy plan may reduce HF hospitalizations Jeremy Moretz, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: ACIST-FFR
• Trial Scorecard: AEIOU
• Trial Scorecard: AKI-MATRIX
• Trial Scorecard: AUGMENT-HF
• Trial Scorecard: CVD-REAL
• Trial Scorecard: DEVOTE
• Trial Scorecard: PESA
• Trial Scorecard: TREAT-AF